RxDoctor Payments Data

Travis Casper, MD

Family Medicine · South Bend, INNPI 1215135918

Payments from drug & device makers

$2,375in general payments, 2019–2025

Across 145 payments — averaging $16.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$580
  • AstraZeneca$189
  • Amgen$152
  • Mallinckrodt Hospital Products Inc.$144
  • Pfizer$140
  • Bayer$130
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$2,370100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,375 in reported general payments places this provider in the 75th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$146,905
Medicare patients
395
Services billed
2,250

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin74$93,605
OzempicSemaglutide80$77,907
JanuviaSitagliptin Phosphate58$75,733
EliquisApixaban48$68,784
XareltoRivaroxaban57$53,483
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$40,903
Breo ElliptaFluticasone/Vilanterol44$23,120
Janumet XrSitagliptin Phos/Metformin Hcl18$22,902
MyrbetriqMirabegron29$20,046
Lantus SolostarInsulin Glargine,hum.Rec.Anlog99$17,401
FarxigaDapagliflozin Propanediol24$17,073
Nurtec OdtRimegepant Sulfate12$17,048
Humalog Kwikpen U-100Insulin Lispro40$12,563
Advair HfaFluticasone Propion/Salmeterol18$7,693
Insulin Lispro Kwikpen U-100Insulin Lispro21$7,438

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$16$93,60574 claims
PfizerEliquis, Nurtec Odt$140$85,83260 claims
Novo NordiskOzempic$84$77,90780 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$58$70,57590 claims
Johnson & JohnsonXarelto$80$53,48357 claims
AstraZenecaFarxiga, Symbicort$189$22,32038 claims
Astellas Pharma US IncMyrbetriq$21$20,04629 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in South Bend

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →